ReviewDiscover oncology2025

Therapeutic positioning of asciminib in chronic myeloid leukemia patients previously treated with multiple tyrosine kinase inhibitors in Qatar.

Rola Ghasoub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.